Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Crystalline Deposits in Vitreous Body, Unspecified Eye
Summary
Crystalline deposits in the vitreous body involve the presence of crystalline material within the vitreous gel, the clear substance filling the eye. This condition may affect vision depending on the size, number, and location of the deposits. The term "unspecified eye" indicates the condition is documented without specifying the right or left eye.
Causes
Crystalline deposits can form due to metabolic disorders, inflammation, or degenerative changes in the eye. They may also result from systemic conditions affecting ocular tissues, such as diabetes or hypercholesterolemia.
Risk Factors
- Age-related changes in the vitreous.
- Underlying metabolic or inflammatory conditions.
- Previous ocular surgeries or trauma.
Symptoms
- Visual disturbances such as floaters or blurred vision.
- Possible glare or reduced visual clarity.
- Symptoms may be mild or asymptomatic in some cases.
Diagnosis
A comprehensive eye examination, including slit-lamp biomicroscopy and fundoscopy, is used to identify crystalline deposits. Imaging studies like ultrasound or optical coherence tomography (OCT) may be employed if the retina is obscured.
Treatment Options
- Observation: For asymptomatic or mild cases.
- Medications: To address underlying causes, if applicable.
- Surgical Intervention: Vitrectomy may be considered for severe or vision-impairing deposits.
Prognosis and Follow-Up
Prognosis depends on the underlying cause and the impact of deposits on vision. Regular follow-up is recommended to monitor for changes or complications.
Complications
- Vision impairment due to deposit size or location.
- Associated ocular conditions, such as retinal detachment or inflammation.
Lifestyle & Prevention
- Manage systemic conditions (e.g., diabetes) to reduce risk.
- Protect eyes from injury.
- Regular eye examinations for early detection.
When to Seek Professional Help
Seek care if experiencing sudden vision changes, increased floaters, or persistent visual disturbances.
Tips for Medical Coders
Use H43.20 for crystalline deposits in the vitreous body when the eye is unspecified. Document whether the condition is unilateral or bilateral if known, as this may impact coding specificity. Ensure clinical documentation supports the absence of eye specification when using this code.
H43.20 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.